Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Hall

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2009
A new probabilistic rule for drug-dug interaction predictionJihao Zhou, Zhaohui Qin, Sara K Quinney, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivoJ Christopher Gorski, Shiew-Mei Huang, Amar Pinto, et al.
Clinical Pharmacology and Therapeutics|June 27, 2025
Comparison of Regression and Categorical Analysis for Pharmacokinetic Data From Renal Impairment StudiesGerald Chun-To So, Ying Grace Li, Stephen D Hall, et al.
Clinical Pharmacology and Therapeutics|December 10, 2003
The interaction between St John's wort and an oral contraceptiveStephen D Hall, Zaiqi Wang, Shiew-Mei Huang, et al.
Clinical Pharmacology and Therapeutics|November 19, 2018
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration RateJill C Chappell, P Kellie Turner, Y Anne Pak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7J Andrew Williams, Barbara J Ring, Varon E Cantrell, et al.
Journal of Pharmaceutical Sciences|November 11, 2014
Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023)William F Annes, Amanda Long, Jennifer W Witcher, et al.
Pharmaceutical Research|January 12, 2023
Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad MethionilY Anne Pak, Maria M Posada, James Bacon, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expressionAmar G Pinto, Ying-Hong Wang, Naga Chalasani, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2018
Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human ClearanceNorikazu Matsunaga, Ayşe Ufuk, Bridget L Morse, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2009
A new probabilistic rule for drug-dug interaction predictionJihao Zhou, Zhaohui Qin, Sara K Quinney, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivoJ Christopher Gorski, Shiew-Mei Huang, Amar Pinto, et al.
Clinical Pharmacology and Therapeutics|June 27, 2025
Comparison of Regression and Categorical Analysis for Pharmacokinetic Data From Renal Impairment StudiesGerald Chun-To So, Ying Grace Li, Stephen D Hall, et al.
Clinical Pharmacology and Therapeutics|December 10, 2003
The interaction between St John's wort and an oral contraceptiveStephen D Hall, Zaiqi Wang, Shiew-Mei Huang, et al.
Clinical Pharmacology and Therapeutics|November 19, 2018
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration RateJill C Chappell, P Kellie Turner, Y Anne Pak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7J Andrew Williams, Barbara J Ring, Varon E Cantrell, et al.
Journal of Pharmaceutical Sciences|November 11, 2014
Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023)William F Annes, Amanda Long, Jennifer W Witcher, et al.
Pharmaceutical Research|January 12, 2023
Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad MethionilY Anne Pak, Maria M Posada, James Bacon, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expressionAmar G Pinto, Ying-Hong Wang, Naga Chalasani, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2018
Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human ClearanceNorikazu Matsunaga, Ayşe Ufuk, Bridget L Morse, et al.
Pageof 14